Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

Elodie Dupuis earned her Master’s degree in biology and biotechnology engineering from the University department, leading her team on the development of innovative HTRF™ and AlphaLISA™ kits for pharma, biotech Mathis holds a biotechnology engineering degree from the National School of Biomolecule Technology of brand recognition for the HTRF technology and accelerate the company’s reagents use in academic labs, biotech serendipity, and partnerships fuel innovation—and how this mindset can transform your research and biotech

Frequently asked questions Webinar University Vault Premium Pricing GPCR Masterclass YC-Biotech YC-VC

GPCR Ecosystem, with the goal is to bring together GPCR scientists, biotech, and pharma leaders as well

pharmacologist with a ~30 years background in academia and industry, working both in big pharma and biotech at Novo Nordisk A/S allowed me to shape a swiss start-up company from a scientifc idea to a thriving Biotech Trejo has presented her studies at 52 national/international meetings and 66 academic seminars across

More broadly, I hope to be a critical contributor to a growing Canadian biotech sector in both scientific

Inoviem scientific in Nov. 2011 by myself we have been regularly working with GPCRs for our pharma and biotech

led to the development and application of light energy transfer methodology to study protein-protein interaction He is the scientific founder of two biotech companies, ModMab Therapeutics , and AntlerA Therapeutics

want to support academic labs with the same high-quality tools, courses, and insights used by leading biotech

neuroscience R&D program with Servier (France) and is the co-founder and CEO of Phrenix Therapeutics, a biotech Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology

What challenges do you face most in your research or biotech journey?

Hoare now consults for biotech and pharmaceutical clients on GPCR data analysis, receptor binding kinetics As an industry pharmacologist, he consults with numerous pharma and biotechs in understanding and applying

GPCR Podcast features leading scientists, innovators, and biotech professionals whose work is advancing

Join a global GPCR community of scientists and biotech leaders. 👉 Join now Unlock the Full Dr.

Computational models are moving beyond interpretation into real-world prediction of ligand-receptor interactions Computational chemists and structural biologists Early-career researchers exploring drug discovery Biotech Trained initially as a biotechnology engineer, Jens discovered his true calling during an internship

Sokhom Pin shares how he built a biotech career around GPCRs, designed a custom PhD path, and led teams

She received her undergraduate degree in Biotechnology from KIIT University in India. his expertise to enhance healthcare outcomes and contribute to the growth of the pharmaceutical and biotech of Pharmaceutical Sciences, Monash University, with a deep interest in understanding drug-receptor interactions

curated intelligence briefings with expert analysis Community access — connect with scientists and biotech

industry-standard assays, designed for regulatory submissions, are backed by partnerships with leading pharma and biotech backgrounds Multiple Mechanisms of Actions (MOA) cAMP accumulation β-Arrestin recruitment Receptor internalization These assays enable complete pharmacological profiling across cAMP, β-arrestin, and internalization. Internalization profiles distinguishing highly versus weakly internalizing agonists.

is an online platform that provides to (i) individuals and businesses such as scientists, students, biotech others with access to advertise, to promote, and market their services and products related to the biotech Either party in this agreement may seek any interim or preliminary relief from a court of competent jurisdiction

focuses on organic synthesis, medicinal chemistry, and the development of GPCR-targeted tools for pharma, biotech adenosine receptor NanoBRET® competitive binding assay enables real-time quantification of ligand–receptor interactions “These tools can dramatically improve how scientists measure ligand-receptor interactions, visualize

At one point, he had a job offer at Roivant (a biotech firm known for repurposing shelved compounds),

Advanced GPCR webinars for pharmacologists and biotech scientists. Live Q&A. These sessions are designed for interaction — scientists asking direct questions and getting real answers

He has received substantial, long-term support from international and national competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology companies Professor Christopoulos has over 360 publications, including in leading international journals such as He has served on the Editorial Board of 8 international journals and was a Councillor of the International his experiences in the pharmaceutical industry, highlighting the differences between big pharma and biotech

He has received substantial, long-term support from international and national competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology companies Professor Christopoulos has over 360 publications, including in leading international journals such as He has served on the Editorial Board of 8 international journals and was a Councillor of the International They also emphasized the significance of fundamental discoveries, the role of biotech, and the need for

He has received substantial, long-term support from international and national competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology companies Professor Christopoulos has over 360 publications, including in leading international journals such as He has served on the Editorial Board of 8 international journals and was a Councillor of the International They also emphasized the significance of fundamental discoveries, the role of biotech, and the need for

and John had a detailed discussion about the prospects of staying in academia versus transitioning to biotech

outside clinical attention Career architecture for bench pharmacologists moving beyond academia and biotech